New IVF drug shows promise in early trial for better egg retrieval
NCT ID NCT07236476
First seen Nov 19, 2025 · Last updated Apr 29, 2026 · Updated 18 times
Summary
This study tests three different doses of a new drug called LY01021 in about 90 women undergoing IVF or ICSI. The goal is to find the best dose to control hormone levels and improve the number of eggs retrieved, fertilization rates, and pregnancy rates. Participants are married women aged 20-40 with normal menstrual cycles and body weight.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASSISTED REPRODUCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University Third Hospital
Beijing, China
Conditions
Explore the condition pages connected to this study.